The molecular genetics underlying basal cell carcinoma pathogenesis and links to targeted therapeutics.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 20800318.
- Also identified by DOI 10.1016/j.jaad.2010.06.054.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Mutations in the sonic hedgehog signaling pathway play a key role in the development of basal cell carcinomas. Specifically, mutations in the PTCH1 (also known as PTCH or PTC1) and SMO genes cause tumor formation through constitutive activation of the pathway. Misregulation of the pathway has also been implicated in the nevoid basal cell carcinoma syndrome and other tumors. Understanding the function of the sonic hedgehog pathway has led to novel strategies for treatment. In this review we highlight the role of the pathway in the pathogenesis of basal cell carcinoma and review potential targeted therapies.
Medical subject headings
- Basal Cell Carcinoma
- Genetic Predisposition to Disease
- Hedgehog Proteins
- Signal Transduction
- Skin Neoplasms